Search hospitals > Nevada > Las Vegas

Comprehensive Cancer Centers of Nevada-Summerlin

Claim this profile
Las Vegas, Nevada 89144
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Stomach Cancer
192 reported clinical trials
3 medical researchers
Photo of Comprehensive Cancer Centers of Nevada-Summerlin in Las VegasPhoto of Comprehensive Cancer Centers of Nevada-Summerlin in Las Vegas

Summary

Comprehensive Cancer Centers of Nevada-Summerlin is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Lung Cancer, Cancer, Breast Cancer, Stomach Cancer and other specialties. Comprehensive Cancer Centers of Nevada-Summerlin is involved with conducting 192 clinical trials across 346 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Henry Igid, MD.

Area of expertise

1Skin Cancer
Global Leader
Comprehensive Cancer Centers of Nevada-Summerlin has run 83 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I
2Lung Cancer
Global Leader
Comprehensive Cancer Centers of Nevada-Summerlin has run 33 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Comprehensive Cancer Centers of Nevada-Summerlin

Breast Cancer
Bladder Cancer
Lung Cancer
Skin Cancer
Prostate Cancer
Bladder Carcinoma
Stomach Cancer
Kidney Cancer
Uterine Tumors
Testicular cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

T-DM1 + Tucatinib

for Breast Cancer

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Image of trial facility.

Mobile Health

for Breast Cancer

This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Comprehensive Cancer Centers of Nevada-Summerlin?
Comprehensive Cancer Centers of Nevada-Summerlin is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Lung Cancer, Cancer, Breast Cancer, Stomach Cancer and other specialties. Comprehensive Cancer Centers of Nevada-Summerlin is involved with conducting 192 clinical trials across 346 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Henry Igid, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security